India Lifts Trade Restrictions on Certain Flat Panel Display Modules, Remdesivir
India lifted its trade restrictions on certain flat panel display modules listed under Harmonized Tariff Schedule headings 8524 and 8525, the Directorate-General of Foreign Trade said. The trade policy for goods exported under subheadings 8524.11.00, "Of liquid crystals"; 8524.12.00, "Of organic light-emitting diodes"; 8524.19.00, "Other"; 8524.91.00, "Of liquid crystals"; 8524.92.00, "Of organic light-emitting diodes"; 8524.99.00, "Other"; and 8525.89.00, "Other"; was changed from "Restricted" to "Free."
Sign up for a free preview to unlock the rest of this article
Export Compliance Daily combines U.S. export control news, foreign border import regulation and policy developments into a single daily information service that reliably informs its trade professional readers about important current issues affecting their operations.
In another Feb. 24 notice, the DGFT moved the trade policy for a series of medicines and their active pharmaceutical ingredients from "Restricted" to "Free." No trade restrictions will apply to Injection remdesivir and remdesivir API, amphotericin B injections, enoxaparin and its API, and intravenous immunoglobulin and its API.